Xi'an Particle Cloud Biotechnology Co., Ltd.

Xi'an Particle Cloud Biotechnology Co., Ltd. (PCB) is an international leading high-tech company focusing on biotechnology, health care, information technology, and manufacturing industries. Established in 2014 in China, PCB's vision is to "Create the bright future of the human life and health." They specialize in providing advanced materials, innovative products, and intelligent equipment for bioengineering, medical health, and advanced manufacturing. PCB has distinguished itself in the field of biodegradable bioceramics, biopolymers, and their composites, leveraging expertise in 3D printing technology of biomaterials. Their groundbreaking Filament-free Printing (FFP) technology allows direct printing of ceramic materials at normal temperature and has applications in medical biology, education, new materials, new energy, and intelligent manufacturing. The company's commitment to R&D of the core technology of 3D printing in regenerative artificial bone has attracted significant attention and investment. In their latest funding round, the Series B investment at 31 October 2023, PCB secured funding from reputable investors including Capitech, Zhengxin Capital, and Tianhong Huacheng. As PCB continues to make strides in their innovative technologies and product offerings, the recent investment signifies a strong endorsement from the investor community. With a vision to create a 3D world for human life and health, PCB is poised to make a meaningful impact in the biotechnology and healthcare sectors.